The research community consensus, articulated in recent systematic reviews, states that BPC-157 should be considered investigational and approached with appropriate caution, but this recommendation stems from limited human clinical data rather than evidence of harm
10.1007/s10157-021-02048-1 203 ShiraishiF.CurtisL
Yes, bruising from Trulicity injections is a recognised common reaction that may affect up to 1 in 10 people
Comparison of biochemical indicators At 12 and 20 weeks of treatment, the semaglutide-intensified treatment group demonstrated significant reductions in fasting plasma glucose, fasting insulin, and HOMA-IR compared to the standard treatment group, with significant differences ( P 0.05) [Table 1]
Semaglutide is an FDA-approved medication designed to assist with weight management by reducing appetite and promoting feelings of fullness